Risultati ricerca pubblicazioni

Essential oils and their main chemical components: the past 20 years of preclinical studies in melanoma

pubblicato su: CANCERS - 2020

Di Martile M., Garzoli S., Ragno R., Del Bufalo D.

Effects of glutathione transferase-targeting nitrobenzoxadiazole compounds in relation to PD-L1 status in human melanoma cells

pubblicato su: CHEMOTHERAPY - 2019

Sciarretta F., Fulci C., Palumbo C., Rotili D., Tentori L., Graziani G., Caccuri A. M.

Functional Characterization of Cholinergic Receptors in Melanoma Cells

pubblicato su: CANCERS - 2020

Lucianò Anna Maria, Tata Ada Maria

Pharmacological applications of Nrf2 inhibitors as potential antineoplastic drugs

pubblicato su: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 2019

Telkoparan-Akillilar P, Suzen S, Saso L.

Metastases to The Breast. A Clinical Series From a Single Institution Experience with Review of the Literature

pubblicato su: ANNALI ITALIANI DI CHIRURGIA - 2020

Sanguinetti Alessandro, Avenia Stefano, Pennetti Pennella Francesca, Chiummariello Stefano, Lucchini Roberta, Galasse Sergio, Macciò Tiziana, Avenia Nicola, Polistena Andrea

In vitro biophysical and biological characterization of lipid nanoparticles Co-encapsulating oncosuppressors miR-199b-5p and miR-204-5p as potentiators of target therapy in metastatic melanoma

pubblicato su: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 2020

Fattore L., Campani V., Ruggiero C. F., Salvati V., Liguoro D., Scotti L., Botti G., Ascierto P. A., Mancini Rita, De Rosa G., Ciliberto G.

Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas. effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization

pubblicato su: CELL COMMUNICATION AND SIGNALING - 2020

Fattore L., Malpicci D., Milite C., Castellano S., Sbardella G., Botti G., Ascierto P. A., Mancini R., Ciliberto G.

Cancer stem cells and the slow cycling phenotype. how to cut the gordian knot driving resistance to therapy in melanoma

pubblicato su: CANCERS - 2020

Fattore Luigi, Mancini Rita, Ciliberto Gennaro

The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma

pubblicato su: EXPERT OPINION ON THERAPEUTIC TARGETS - 2019

Fattore Luigi, Mancini Rita, Ascierto Paolo Antonio, Ciliberto Gennaro

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma. Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin

pubblicato su: CANCERS - 2019

Ruggiero Ciro Francesco, Malpicci Debora, Fattore Luigi, Madonna Gabriele, Vanella Vito, Mallardo Domenico, Liguoro Domenico, Salvati Valentina, Capone Mariaelena, Bedogni Barbara, Ascierto Paolo Antonio, Mancini Rita, Ciliberto Gennaro

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma

pubblicato su: CELL DEATH AND DIFFERENTIATION - 2018

Fattore L, Ruggiero Cf, Pisanu Me, Liguoro D, Cerri A, Costantini S, Capone F, Acunzo M, Romano G, Nigita G, Mallardo D, Ragone C, Carriero Mv, Budillon A, Botti G, Ascierto Pa, Mancini R, Ciliberto G.

Ion channel expression in human melanoma samples. in silico identification and experimental validation of molecular targets

pubblicato su: CANCERS - 2019

D’Arcangelo Daniela, Scatozza Francesca, Giampietri Claudia, Marchetti Paolo, Facchiano Francesco, Facchiano Antonio

Loss of two-pore hannel 2 (TPC2) expression increases the metastatic traits of melanoma cells by a mechanism involving the hippo signalling pathway and store-operated calcium entry

pubblicato su: CANCERS - 2020

D'Amore Antonella, Hanbashi Ali Ahmed, Di Agostino Silvia, Palombi Fioretta, Sacconi Andrea, Voruganti Aniruddha, Taggi Marilena, Canipari Rita, Blandino Giovanni, Parrington John, Filippini Antonio

Ricerc@Sapienza